Abstract
Both type 1 and type 2 diabetes mellitus (DM) are associated with mental disorders, e.g., eating disorders and depression. Comorbid mental disorders are associated with impaired glycemic control, a higher risk of diabetes complications, and even a higher mortality. Mental problems can also negatively influence adherence to the necessary medical regimens. Regarding psychopharmacological treatment, the choice of drug is essential because many antidepressants and antipsychotics can cause substantial weight gain, which exerts a negative influence on glycemic control. Cognitive behavioral approaches have been shown to successfully reduce mental comorbidity and to also positively influence glycemic control. In their 2022 guidelines, the American Diabetes Association thus recommends that psychosocial care should be integrated into a collaborative, patient-centered approach and be provided to all people with DM, with the goal to optimize health outcomes and health-related quality of life.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
